Researchers from the Biointeractomics Laboratory of the Institute of Plant Biochemistry and Photosynthesis (IBVF) participate in the pan-European interdisciplinary research network MOBIEU, made up of 62 research groups from 23 countries.
In the Executive Committee of this COST Action of the prestigious European Cooperation in Science and Technology programme there are two delegates for each country, and the principal investigator of the biointeractomics laboratory, Dr. Irene Díaz-Moreno, is part of it representing Spain.
Molecular biophysics is an interdisciplinary and constantly evolving field whose objective is the study of biological assemblies and macromolecules at an intermediate level between structural descriptions at atomic resolution and observations at the cellular level, with significant applications in biomedicine and drug discovery. The MOBIEU network is an interdisciplinary and pan-European cluster to facilitate synergy between diverse unimolecular, thermodynamic, real-time microfluidic, hydrodynamic, and spectroscopic methods.
This network is open and will create an optimal breeding ground for the development of innovative biophysical methods in terms of data acquisition, analysis and modelling, as well as for the design of unprecedented and ambitious combinations of methodologies, the aim of which will be to decipher biological phenomena more efficiently and to solve important biomedical questions.
MOBIEU will disseminate the knowledge generated through a comprehensive training programme, giving priority to young researchers who are in the early stages of their careers.
A special effort will also be made to build a new European distribution of infrastructures for molecular biophysics, with the aim of facilitating transnational access to equipment and technicians, especially by researchers in countries with low participation in COST programmes, the so-called Inclusiveness Target Countries.
MOBIEU will serve as a platform for scientists to establish contacts with equipment manufacturers (in the concept or prototype phase) thus allowing them to establish agreements to define and develop equipment that in the future will fully satisfy the needs of the biomedical and life sciences communities.
Finally, it should be noted that among the infrastructures included in the network is the cicCartuja Biomolecular Interactions Platform
More information on this COST action funded by the European Cooperation in Science and Technology programme at http://www.cost.eu/COST_Actions/ca/CA15126
